Loading
Latest filing published 14 Dec 2021 for Clarus Therapeutics Holdings, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Steven A. Bourne on record concern Clarus Therapeutics Holdings, Inc., in the capacity of senior executive. In total, 2 filings cover trades dated from 9 September 2021 to 11 December 2021.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 14 December 2021, reports a share grant in Clarus Therapeutics Holdings, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations